IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 1662 
Small font sizeDefault font sizeIncrease font size
Read this article


    Article Cited by others


The evaluation of efficacy and safety of methotrexate and pioglitazone in psoriasis patients: A randomized, open-labeled, active-controlled clinical trial

Abidi Afroz, Rizvi Dilshad Ali, Saxena Kshitij, Chaudhary Savita, Ahmad Ali

Year : 2020| Volume: 52| Issue : 1 | Page no: 16-22

   This article has been cited by
1 Effects of Hypolipidemic Drugs on Psoriasis
Mateusz Matwiejuk, Hanna Mysliwiec, Olivia Jakubowicz-Zalewska, Adrian Chabowski, Iwona Flisiak
Metabolites. 2023; 13(4): 493
[Pubmed]  [Google Scholar] [DOI]
2 The Role of Transcription Factor PPAR-? in the Pathogenesis of Psoriasis, Skin Cells, and Immune Cells
Vladimir V. Sobolev, Ekaterina Tchepourina, Irina M. Korsunskaya, Natalia A. Geppe, Svetlana N. Chebysheva, Anna G. Soboleva, Alexandre Mezentsev
International Journal of Molecular Sciences. 2022; 23(17): 9708
[Pubmed]  [Google Scholar] [DOI]
3 Peroxisome proliferator-activator receptor ? and psoriasis, molecular and cellular biochemistry
Xiran Lin, Xianmin Meng, Zhiqi Song, Jingrong Lin
Molecular and Cellular Biochemistry. 2022;
[Pubmed]  [Google Scholar] [DOI]
4 Methotrexate Dosing Regimen for Plaque-type Psoriasis: An Update of a Systematic Review
Astrid M. van Huizen, Rosie Sikkel, Anouk G.M. Caron, Stef P. Menting, Phyllis I. Spuls
Journal of Dermatological Treatment. 2022; : 1
[Pubmed]  [Google Scholar] [DOI]
5 Treatment Modalities of Psoriasis: A Focus on Requisite for Topical Nanocarrier
Arya K. Ramanunny, Sheetu Wadhwa, Divya Thakur, Sachin K. Singh, Rajesh Kumar
Endocrine, Metabolic & Immune Disorders - Drug Targets. 2021; 21(3): 418
[Pubmed]  [Google Scholar] [DOI]


Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow